ArticlePharmacology research & perspectives2018

Antidyslipidemic potential of a novel farnesoid X receptor antagonist in a hamster model of dyslipidemia: Comparative studies of other nonstatin agents.

Emiko Shinozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.